DCM
HCAT icon

DGS Capital Management’s Health Catalyst HCAT Stock Holding History

DGS Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
+11,013
New +$20.7K ﹤0.01% 628

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGS Capital Management's HCAT Position: Q1 2026 in Review

DGS Capital Management opened a new position in Health Catalyst (HCAT) in Q1 2026: 11,013 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #628 among its holdings.

130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • DGS Capital Management held 11,013 shares of Health Catalyst worth $14K as of Q1 2026.
  • Health Catalyst was a new DGS Capital Management position in Q1 2026.
  • Health Catalyst made up ﹤0.01% of DGS Capital Management's portfolio in Q1 2026, its #628 holding.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.